Fonet.Is
FONET.IS operates in the healthcare equipment sector, specializing in the design, development, and distribution of advanced medical equipment and technology.
Business. FONET.IS operates in the healthcare equipment sector, specializing in the design, development, and distribution of advanced medical equipment and technology.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
FONET.IS operates in the healthcare equipment sector, specializing in the design, development, and distribution of advanced medical equipment and technology.
FONET.IS maintains a strong liquidity position with a current ratio of 2.34, indicating the company can cover its short-term liabilities more than twice over. However, the company has a negative net cash position after subtracting total debt, which introduces a medium liquidity risk. The debt-to-equity ratio is low at 0.03, suggesting minimal leverage and a conservative capital structure.
In terms of profitability, FONET.IS generates a return on equity (ROE) of 13.18% and a return on assets (ROA) of 12.1%, both of which are strong indicators of efficient capital use and asset management. These figures are well above the industry median for ROE and ROA, which are typically in the 8-10% range for companies in the healthcare equipment sector.
The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no material geographic diversification reported. This lack of diversification may expose the company to higher operational and market risks if demand in its primary market fluctuates.
FONET.IS has demonstrated consistent revenue growth, with a free cash flow of 114.17 million TRY and an operating cash flow of 343.00 million TRY. While the company has not provided forward-looking guidance, the positive cash flow and strong operating income suggest a stable growth trajectory.
The risk assessment indicates a low dilution potential, with no significant dilution sources identified in the latest filings. The company has not issued new shares in the past year, and there are no indications of a pending equity offering or ATM program. However, the negative net cash position and the presence of long-term debt may require the company to raise additional capital in the future, which could introduce dilution risk.
Recent filings and transcripts do not indicate any material events or strategic shifts. The company continues to focus on its core business of medical equipment and technology, with no new product launches or major acquisitions disclosed in the latest financial statements.
- FONET.IS has a strong liquidity position with a current ratio of 2.34, but a negative net cash position introduces medium liquidity risk.
- The company's ROE of 13.18% and ROA of 12.1% are well above industry medians, indicating strong profitability and asset efficiency.
- Revenue is concentrated in a single business segment, with no material geographic diversification, increasing exposure to market fluctuations.
- Free cash flow and operating cash flow are positive, suggesting a stable growth trajectory.
- Dilution risk is currently low, but the negative net cash position may necessitate future capital raising.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- FONET.IS Market data — financials · 2026-05-27